BRIEF published on 05/27/2025 at 17:16, 1 year 5 months ago INDUS Shareholders Focus on Growth and Future Resilience Growth Strategy Financial Performance INDUS Holding AG Internationalization Annual Meeting 2025
PRESS RELEASE published on 05/27/2025 at 17:11, 1 year 5 months ago 2025 Annual Meeting of INDUS Shareholders: Actively shaping the future and seizing growth opportunities INDUS Holding AG focuses on acquisitions, internationalization, and engineering competence at the 2025 Annual Shareholders' Meeting. Dividend of EUR 1.20 per share approved Acquisitions Dividend Payment INDUS Holding AG Internationalization Engineering Competence
BRIEF published on 05/19/2025 at 11:13, 1 year 5 months ago INDUS Holding AG's Q1 2025 Performance Amid Economic Challenges Supply Chain INDUS Holding AG Economic Impact Q1 Performance US Tariffs
PRESS RELEASE published on 05/19/2025 at 11:08, 1 year 5 months ago Original-Research: INDUS Holding AG (von Parmantier & Cie. GmbH): Buy Research report on INDUS Holding AG by Parmantier & Cie. GmbH reveals Q1 2025 performance, impact of US tariff policy, acquisitions, and financial outlook for 2025 Financial Outlook INDUS Holding AG Research Report Q1 2025 US Tariff Policy
BRIEF published on 05/15/2025 at 09:05, 1 year 5 months ago INDUS Holding AG: Q1 Results and Updated Projections Order Intake INDUS Holding AG Q1 Results Guidance Update Engineering Demand
PRESS RELEASE published on 05/15/2025 at 09:00, 1 year 5 months ago Original-Research: INDUS Holding AG (von NuWays AG): BUY INDUS Holding AG research update: mixed Q1 figures with soft start anticipated, solid order intake for H2'25e. Sales below expectations, Engineering demand strong Order Intake Research Update Engineering INDUS Holding AG Q1 Figures
BRIEF published on 05/14/2025 at 07:34, 1 year 5 months ago INDUS Group's Financial Performance in Q1 2025 Acquisitions Market Outlook Indus Group Q1 2025 Sales And EBITA
PRESS RELEASE published on 05/14/2025 at 07:29, 1 year 5 months ago INDUS Group generates sales of EUR 402.4 million and adjusted EBITA of EUR 24.9 million in Q1 2025 INDUS Group reports Q1 2025 sales of EUR 402.4 million with adjusted EBITA of EUR 24.9 million. Solid performance driven by the Engineering segment Sales Adjusted EBITA Indus Group Q1 2025 Engineering Segment
BRIEF published on 05/09/2025 at 09:05, 1 year 5 months ago INDUS Holding AG Faces Supply Chain Challenges but Remains a Buy INDUS Holding AG Supply Chain Resilience NuWays Recommendation Tungsten Supply Chain BETEK Challenges
PRESS RELEASE published on 05/09/2025 at 09:00, 1 year 5 months ago Original-Research: INDUS Holding AG (von NuWays AG): BUY NuWays AG's update research report on INDUS Holding AG highlights FY'25 outlook reduction due to tungsten supply chain issues, affecting the Materials Solutions segment NuWays AG INDUS Holding AG Research Report FY'25 Outlook Tungsten Supply Chains
Published on 11/04/2026 at 23:10, 4 hours 40 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 4 hours 50 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 5 hours 35 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 5 hours 45 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 03:10, 39 minutes ago SensAI Veritas Launches SensAI Gateway™ and SensAI Helm™: Bringing Risk Intelligence to the Moment of Trust
Published on 11/05/2026 at 00:02, 3 hours 47 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 8 hours 8 minutes ago EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 8 hours 24 minutes ago Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:43, 9 hours 6 minutes ago EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Published on 11/04/2026 at 18:00, 9 hours 49 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 17:44, 10 hours 6 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Published on 11/04/2026 at 11:56, 15 hours 53 minutes ago Mersen: Number of shares and voting rights as of October 31, 2026
